CNET editors independently choose every product and service we cover. Though we can’t review every …
Read More »Why Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher Today
In the pharmaceutical world, it’s never good for a company to stumble in a hot therapeutic area, especially if it has some determined rivals competing in the same segment. That was the dynamic behind Wegovy and Ozempic developer Novo Nordisk‘s (NYSE: NVO) Friday stumble on the stock exchange –following its …
Read More »